By clicking on "Accept", you agree to the use of cookies on your device to improve navigation on the site, analyze its use and contribute to our marketing efforts. Read more
 
  • Products & Solutions
    Products & Solutions
    • Pharmaceuticals
      Pharmaceuticals
    • Animal Health
      Animal Health
    • Wellness and Beauty
      Wellness and Beauty
    • Healthcare Technologies
      Healthcare Technologies
      • Medical Consumables
      • Medical Equipment
      • Medical Laboratory
  • Expertise
  • Blog
  • About us
  • Careers
  • Contact
    • Medical Practitioner
    • Pharmacist
    • Veterinarian

MENU

  • Products & Solutions
    • Pharmaceuticals
    • Animal Health
    • Wellness and Beauty
    • Healthcare Technologies
      • Medical Consumables
      • Medical Equipment
      • Medical Laboratory
  • Expertise
  • Blog
  • About us
  • Careers
  • Pro
  • Contact
  • HEALTHACTIV CORPORATE
  • ANIMAL CARE
  • WELLNESS & BEAUTY
  • VITABIOTICS
  • Topicrem
  • Biocyte
  • HEALTHACTIV CORPORATE

CONNECT WITH US

  • Healthcare
  • Animal care
  • Wellness & Beauty
  • HealthActiv news
  • Healthcare
2019, August 16

Treating Flu: Know when to prescribe antibiotics

It is a well-established fact that improper use of antibiotics does more harm than good. Clinicians should consider antibiotic treatment only if symptoms persist with no improvement for 10 or more days.

Antimicrobial therapy is recommended when patients exhibit complications. Patients are likely to have or are at higher risk of developing complications if they:

  • Are systemically unwell
  • Have symptoms and signs suggestive of serious illnesses (for example pneumonia, mastoiditis)
  • Have pre-existing comorbidities such as lung, cardiac, renal, liver, and neuromuscular disease, and immunosuppression, or young children who were born premature
  • Are older than 65 years and have type 1 or type 2 diabetes, history of congestive heart failure, are on steroids or have needed hospitalization in the previous year


Physicians are advised to consider antibiotic therapy in people with FeverPAIN score of 4 or 5, or Centor score of 3 or 4.


FeverPAIN criteria is as follows:

  • Fever (during previous 24 hours)
  • Purulence (pus on tonsils)
  • Attend rapidly (within 3 days after onset of symptoms)
  • Severely Inflamed tonsils
  • No cough or coryza (inflammation of mucus membranes in the nose)


Each of the criteria scores 1 point (maximum score of 5). A higher score indicates more severe symptoms and likely a bacterial (streptococcal) cause. A score of 4 or 5 is thought to be associated with 62-65% likelihood of isolating streptococcus.


Centor criteria is as follows:

  • Tonsillar exudate
  • Tender anterior cervical lymphadenopathy or lymphadenitis
  • History of fever (over 38°C)
  • Absence of cough


Each of the Centor criteria scores 1 point (maximum score of 4). A score of 3 or 4 is thought to be associated with 32-56% likelihood of isolating streptococcus.


Which antibiotics to prescribe for initial empiric antimicrobial therapy?

  • Amoxicillin therapy is advisable for LRTI. However, amoxicillin should be avoided if infectious mononucleosis is suspected. For patients who are allergic to penicillin, clarithromycin or azithromycin therapy may be used.
  • Phenoxymethylpenicillin is advisable for sore throat. For patients who are allergic to penicillin, clarithromycin or Erythromycin therapy may be used.


When antibiotics are not indicated, physicians should reassure patients that antibiotics are not needed immediately as they are unlikely to make any difference to the symptoms and may on the other hand, cause side effects, such as, diarrhea vomiting and rash.



Author: Dr Reshma Ramracheya is a group leader at the University of Oxford with over 18 years of experience in teaching and medical research.

Reference:

  • Hay AJ, McCauley JW. The WHO global influenza surveillance and response system (GISRS)—A future perspective. Influenza Other Respi Viruses. 2018;12:551–557. https://doi.org/10.1111/irv.12565.
  • Hemila H., Chalker E., Douglas B. The Cochrane Library; 2010.
  • Sabbaghi A, Miri SM, Keshavarz M, Zargar M, Ghaemi A. Inactivation methods for whole influenza vaccine production. Rev Med Virol. 2019 Jul 23:e2074. doi: 10.1002/rmv.2074.
  • CDC, Centers for Disease Control and Prevention (https://www.cdc.gov/vaccines/pubs/pinkbook/flu.html)
  • NICE, National Institute for Health and Care (https://www.nice.org.uk/guidance/conditions-and-diseases/infections/influenza)
Back to Blog

Read also

  • Healthcare
2025, April 18
Understanding Meniscus Tear, a Common Knee Injury
  • HealthActiv news
2025, April 08
Meeting Global Standards: HealthActiv Qualified & Validated by Strategnos for Temperature Mapping
  • Wellness & Beauty
2025, March 28
L'aromathérapie et la santé articulaire : une approche naturelle pour soulager et prévenir
  • Healthcare
2025, March 04
L'importance du fer pour la santé des bébés et des enfants
logo HealthActiv
15 Reserves St, Les Salines
PO Box 540, Port Louis, Mauritius
+230 203 3500
info@healthactiv.mu

CONNECT WITH US ON SOCIAL MEDIA

Our facebook pages
  • Healthactiv corporate
  • Wellness & Beauty
  • Animal care
  • Vitabiotics
  • Topicrem
  • Biocyte
Our Linkedin page
  • Healthactiv corporate
  • POLICIES
  • Privacy Notice
  • Quality Policy
Copyright 2019 - 2025 HealthActiv
ibl
Visit iblgroup.com